Global MI Neurosurgery Devices Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Neuroendoscopes, Stereotactic Systems, Aneurysm Clips, Shunts, and Others), By Application (Intracranial Tumors, Stroke, Cerebral Aneurysms, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global MI Neurosurgery Devices Market Insights Forecasts to 2035

• The Global MI Neurosurgery Devices Market Size Was Estimated at USD 3.40 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.1% from 2025 to 2035
• The Worldwide MI Neurosurgery Devices Market Size is Expected to Reach USD 6.52 Billion by 2035
• Asia Pacific is Expected to Grow the fastest during the forecast period.

According to a research report published by Spherical Insights & Consulting, The Global MI Neurosurgery Devices Market Size was worth around USD 3.40 Billion in 2024 and is predicted to grow to around USD 6.52 Billion by 2035 with a compound annual growth rate CAGR of 6.1% from 2025 and 2035. The global MI neurosurgery devices market is propelled by the increased prevalence of neurological conditions such as brain aneurysms, strokes, and intracranial tumours. The desire for efficient and minimally invasive treatment alternatives has increased due to the continually rising global burden of neurological illnesses. 

Market Overview

The MI neurosurgery devices refer to specialised surgical instruments and systems that allow neurosurgeons to use sophisticated visualisation and navigation techniques to execute treatments through tiny incisions, minimising patient stress and speeding recovery. A more patient-centered approach to treatment is an encouraging option for the market for minimally invasive neurosurgical technologies. Clinicians are focused on surgical procedures that improve outcomes for patients, allow for quicker recovery, and lead to fewer complications afterwards. By improving the outcome for patients, decreasing length of stay in the hospital, decreasing costs of medical care, and improving quality of life, minimally invasive neurosurgical intervention supports these aims. Further, from a patient-centered care model of innovative practice, potentially less infection is a desired outcome of image-based procedure planners, robotic surgeries, and neuroendoscopic procedures. As patient-centered care models become more prevalent in hospitals and operating centres that utilize minimally invasive neurosurgery technologies, the demand for technologies will increase. The demand drives innovation and market development, and will provide device manufacturers with major growth opportunities.

Governments worldwide are taking a number of deliberate measures to boost the market for MI neurosurgical devices. The FDA in the United States has implemented programs such as the Breakthrough Devices Program, the Digital Health Centre of Excellence, and the Total Product Life Cycle Advisory Program to streamline clearance procedures and accelerate device availability and commercialisation.

Report Coverage

This research report categorizes the MI neurosurgery devices market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the MI neurosurgery devices market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the MI neurosurgery devices market. 

Driving Factors

The growth of the global MI neurosurgery devices market is boosted by the increasing prevalence of neurological diseases, along with advancements in technology. The evolution and implementation of robotics and artificial intelligence in neurosurgery procedures is one significant opportunity. The application of robotics and artificial intelligence has the potential to improve patient care, reduce recovery times, and improve precision and efficacy in surgical techniques. Companies that invest in robotics and artificial intelligence for neurosurgery have a unique market share advantage and the growing demand for advanced surgical techniques. Another exciting possibility in the MI neurosurgery devices market is entering emerging markets.

Restraining Factors

The global MI neurosurgery devices market faces obstacles like minimally invasive neurosurgeries require high-quality instruments with higher accuracy. Fluency and proper education from qualified specialists are crucial, as they limit the potential harm to the patient with minimally invasive procedures. 

Market Segmentation

The MI neurosurgery devices market share is classified into product type and application.

• The neuroendoscopes segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the product type, the MI neurosurgery devices market is divided into neuroendoscopes, stereotactic systems, aneurysm clips, shunts, and others. Among these, the neuroendoscopes segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The segment is driven because it provide higher visibility and accuracy during procedures, thereby enhancing their impact on the market. Neuroendoscopes also provide minimally invasive procedures, and since they also use local anaesthesia, patient recovery and hospital time are very low. These pieces of instrumentation are very beneficial when performing protocols or procedures that involve the management of cerebral aneurysms or intracranial tumours, since accuracy is very important. 

• The intracranial tumors segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the MI neurosurgery devices market is divided into intracranial tumors, stroke, cerebral aneurysms, and others. Among these, the intracranial tumors segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth is propelled as it is very desirable to be able to provide minimally invasive surgery that is also of good accuracy. While the very basis of MI neurosurgery relies on neuroendoscopes and stereotactic systems, MI neurosurgery is very beneficial in terms of accurate removal of tumours and less damage to the surrounding brain tissue. The factors that are driving growth are the advancements in respect to diagnostic imaging and the prevalence rates of brain tumours.

Regional Segment Analysis of the MI Neurosurgery Devices Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the MI neurosurgery devices market over the predicted timeframe.

North America is anticipated to hold the largest share of the MI neurosurgery devices market over the predicted timeframe. The North American region drives as considered to have the high cost of healthcare, the high incidence of neurological disorders, and the advanced healthcare infrastructure. Increasing government support for research and development in the field of neurology and neurosurgery in North America has spurred the further uptake of MI neurosurgery. The region has a number of significant market players, and continued technological advancements contribute to its position.

Asia Pacific is expected to grow at a rapid CAGR in the MI neurosurgery devices market during the forecast period. The Asia Pacific region has expanded due to the increasing demand for minimally invasive surgical techniques, increased awareness of neurological disorders, and rapid development of healthcare infrastructure are primary drivers of this growth. The growing ambition of countries such as China, India, and Japan to develop healthcare, and particularly improve their neurosurgical skills, has resulted in more funding for healthcare overall. The expansion of a middle class, coupled with rising healthcare costs in the region, will also inform the growth of the market.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the MI neurosurgery devices market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Medtronic Plc
• Stryker Corporation
• Johnson & Johnson (DePuy Synthes)
• B. Braun Melsungen AG
• Integra LifeSciences Holdings Corporation
• Zimmer Biomet Holdings, Inc.
• Boston Scientific Corporation
• Smith & Nephew plc
• Abbott Laboratories
• Penumbra, Inc.
• MicroPort Scientific Corporation
• Others 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In April 2024, Dr Reddy’s launched a drug-free, noninvasive device to manage migraines. The device is named Nerivio. Nerivio is supported by Dr. Reddy’s patient support program, which is M-free. The program is a comprehensive support system that will enhance the journey of patients. The services will include onboarding and counseling of patients, device demonstrations, doorstep delivery, flexible payment options, informative content, and dedicated customer care service. 

• In June 2022, Boston Scientific agreed to acquire a majority stake in M.I. Tech, a South Korean manufacturer and distributor of non-vascular metal stents used for endoscopic and urologic procedures. The deal was valued at approximately USD 230 million, with Boston Scientific paying approximately USD 11 per M.I. Tech share.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the MI neurosurgery devices market based on the following segments: 

Global MI Neurosurgery Devices Market, By Product Type

• Neuroendoscopes
• Stereotactic Systems
• Aneurysm Clips
• Shunts
• Others

Global MI Neurosurgery Devices Market, By Application 

• Intracranial Tumors
• Stroke
• Cerebral Aneurysms
• Others

Global MI Neurosurgery Devices Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa